Riedel's thyroiditis risk factors: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
m (Bot: Removing from Primary care) |
||
| (10 intermediate revisions by 2 users not shown) | |||
| Line 4: | Line 4: | ||
{{CMG}}; {{AE}} {{MMF}} | {{CMG}}; {{AE}} {{MMF}} | ||
==Overview== | ==Overview== | ||
Common risk factors in the development of Riedel's thyroiditis include [[Genetics|genetic factors]], medications such as [[lysergic acid]], [[ergotamine]], [[serotonin]], and other [[autoimmune disease|autoimmune diseases]] such as [[Graves’ disease]] and [[Hashimoto's thyroiditis]]. | |||
==Risk Factors== | ==Risk Factors== | ||
===Common Risk Factors=== | ===Common Risk Factors=== | ||
Common risk factors in the development of Riedel's thyroiditis include: | Common risk factors in the development of Riedel's thyroiditis include:<ref name="urlCurrent Concepts on Riedel Thyroiditis | Pathology Patterns Reviews | Oxford Academic">{{cite web |url=https://doi.org/10.1309/NUU88VAFR9YEHKNA |title=Current Concepts on Riedel Thyroiditis | Pathology Patterns Reviews | Oxford Academic |format= |work= |accessdate=}}</ref><ref name="pmid8120524">{{cite journal |vauthors=Zimmermann-Belsing T, Feldt-Rasmussen U |title=Riedel's thyroiditis: an autoimmune or primary fibrotic disease? |journal=J. Intern. Med. |volume=235 |issue=3 |pages=271–4 |year=1994 |pmid=8120524 |doi= |url=}}</ref><ref name="pmid4413980">{{cite journal |vauthors=Drury MI, Sweeney EC, Heffernan SJ |title=Invasive fibrous (Riedel's) thyroiditis |journal=Ir Med J |volume=67 |issue=14 |pages=388–90 |year=1974 |pmid=4413980 |doi= |url=}}</ref><ref name="urlChronic thyroiditis: A case showing features of both riedels and hashimotos thyroiditis - Merrington - 1948 - British Journal of Surgery - Wiley Online Library">{{cite web |url=http://dx.doi.org/10.1002/bjs.18003514015 |title=Chronic thyroiditis: A case showing features of both riedel's and hashimoto's thyroiditis - Merrington - 1948 - British Journal of Surgery - Wiley Online Library |format= |work= |accessdate=}}</ref><ref name="Invasive Fibrous (Riedel's) Thyroiditis">{{cite journal |vauthors=Hines RC, Scheuermann HA, Royster HP |title=Invasive Fibrous (Riedel's) Thyroiditis With Bilateral Fibrous Parotitis.|journal=JAMA|pages=869-871 |year=1970 |doi=10.1001/jama.1970.03170310147054 |url=http://jamanetwork.com/journals/jama/article-abstract/355936}}</ref><ref name="urlRiedels Thyroiditis: A Clinical Review | The Journal of Clinical Endocrinology & Metabolism | Oxford Academic">{{cite web |url=https://doi.org/10.1210/jc.2011-0617 |title=Riedel's Thyroiditis: A Clinical Review | The Journal of Clinical Endocrinology & Metabolism | Oxford Academic |format= |work= |accessdate=}}</ref><ref name="pmid21568724">{{cite journal |vauthors=Fatourechi MM, Hay ID, McIver B, Sebo TJ, Fatourechi V |title=Invasive fibrous thyroiditis (Riedel thyroiditis): the Mayo Clinic experience, 1976-2008 |journal=Thyroid |volume=21 |issue=7 |pages=765–72 |year=2011 |pmid=21568724 |doi=10.1089/thy.2010.0453 |url=}}</ref> | ||
*Genetic factors | *[[Genetics|Genetic factors]] | ||
*Medications | *Medications | ||
**Lysergic acid | **[[Lysergic acid]] | ||
**Ergotamine | **[[Ergotamine]] | ||
**Serotonin | **[[Serotonin]] | ||
**Dihydroergotamine | **[[Dihydroergotamine]] | ||
**Hydralazine | **[[Hydralazine]] | ||
**Methyldopa | **[[Methyldopa]] | ||
**Methysergide | **[[Methysergide]] | ||
**Acetazolamide | **[[Acetazolamide]] | ||
**Phenacetin | **[[Phenacetin]] | ||
**β-blockers | **[[β-blockers]] | ||
*Other autoimmune diseases | *Other [[autoimmune diseases]] | ||
**[[Graves’ disease]] | |||
**[[Hashimoto's thyroiditis|Hashimoto’s thyroiditis]] | |||
**Multifocal idiopathic fibrosclerosis | |||
**[[Addison's disease|Addison’s disease]] | |||
**[[Pernicious anemia]] | |||
*[[Smoking]] | |||
| Line 30: | Line 36: | ||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} | ||
| |||
[[Category:Medicine]] | |||
[[Category:Endocrinology]] | |||
[[Category:Up-To-Date]] | |||
Latest revision as of 00:02, 30 July 2020
|
Riedel's thyroiditis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Riedel's thyroiditis risk factors On the Web |
|
American Roentgen Ray Society Images of Riedel's thyroiditis risk factors |
|
Risk calculators and risk factors for Riedel's thyroiditis risk factors |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Furqan M M. M.B.B.S[2]
Overview
Common risk factors in the development of Riedel's thyroiditis include genetic factors, medications such as lysergic acid, ergotamine, serotonin, and other autoimmune diseases such as Graves’ disease and Hashimoto's thyroiditis.
Risk Factors
Common Risk Factors
Common risk factors in the development of Riedel's thyroiditis include:[1][2][3][4][5][6][7]
- Genetic factors
- Medications
- Other autoimmune diseases
- Graves’ disease
- Hashimoto’s thyroiditis
- Multifocal idiopathic fibrosclerosis
- Addison’s disease
- Pernicious anemia
- Smoking
References
- ↑ "Current Concepts on Riedel Thyroiditis | Pathology Patterns Reviews | Oxford Academic".
- ↑ Zimmermann-Belsing T, Feldt-Rasmussen U (1994). "Riedel's thyroiditis: an autoimmune or primary fibrotic disease?". J. Intern. Med. 235 (3): 271–4. PMID 8120524.
- ↑ Drury MI, Sweeney EC, Heffernan SJ (1974). "Invasive fibrous (Riedel's) thyroiditis". Ir Med J. 67 (14): 388–90. PMID 4413980.
- ↑ "Chronic thyroiditis: A case showing features of both riedel's and hashimoto's thyroiditis - Merrington - 1948 - British Journal of Surgery - Wiley Online Library".
- ↑ Hines RC, Scheuermann HA, Royster HP (1970). "Invasive Fibrous (Riedel's) Thyroiditis With Bilateral Fibrous Parotitis". JAMA: 869–871. doi:10.1001/jama.1970.03170310147054.
- ↑ "Riedel's Thyroiditis: A Clinical Review | The Journal of Clinical Endocrinology & Metabolism | Oxford Academic".
- ↑ Fatourechi MM, Hay ID, McIver B, Sebo TJ, Fatourechi V (2011). "Invasive fibrous thyroiditis (Riedel thyroiditis): the Mayo Clinic experience, 1976-2008". Thyroid. 21 (7): 765–72. doi:10.1089/thy.2010.0453. PMID 21568724.